1. EP38 Secukinumab provides sustained improvement of enthesitis in patients with ankylosing spondylitis: pooled analysis of four pivotal Phase 3 studies. (20th April 2020) Authors: Barkham, Nick; Schett, Georg; Baraliakos, Xenofon; van den Bosch, Filip; Deodhar, Atul; Gensler, Lianne S; Ǿstergaard, Mikkel; Agawane, Shital; Gupta, Ayan Das; Mpofu, Shephard; Fox, Todd; Winseck, Adam; Shete, Abhijit; Porter, Brian Journal: Rheumatology Issue: Volume 59(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0380 SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES. (June 2019) Authors: Schett, Georg; Baraliakos, Xenofon; Bosch, Filip van den; Deodhar, Atul; Gensler, Lianne S.; Ǿstergaard, Mikkel; Agawane, Shital; Gupta, Ayan Das; Mpofu, Shephard; Fox, Todd; Winseck, Adam; Shete, Abhijit; Porter, Brian Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗